---
schema_version: "secwatch.filing_event.v1"
accession: "0001737287-25-000070"
form_type: "8-K"
ticker: "ALLO"
cik: "0001737287"
company_name: "Allogene Therapeutics, Inc."
filed_at: "2025-06-23T23:59:59+00:00"
generated_at: "2026-05-18T23:55:30.334698+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Allogene shareholders elect three Class I directors, approve say-on-pay, ratify auditor

## Summary
- Elizabeth Barrett, Arie Belldegrun, and David Chang elected as Class I directors with >131M votes for each.
- Advisory vote on NEO compensation approved: 139.9M for, 14.2M against, 3.2M abstain.
- Ratification of Ernst & Young as auditor for FY2025: 190.1M for, 414.6K against.
- All proposals passed with no broker non-votes on auditor ratification.

## SEC filing metadata
- accession: 0001737287-25-000070
- form_type: 8-K
- ticker: ALLO
- cik: 0001737287
- company_name: Allogene Therapeutics, Inc.
- filed_at: 2025-06-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737287/000173728725000070/0001737287-25-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737287/000173728725000070/allo-20250618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001737287-25-000070
- JSON: https://secwatch.observer/filing/0001737287-25-000070.json
- Plain text: https://secwatch.observer/filing/0001737287-25-000070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.